FR2087823A5 - - Google Patents
Info
- Publication number
- FR2087823A5 FR2087823A5 FR7110229A FR7110229A FR2087823A5 FR 2087823 A5 FR2087823 A5 FR 2087823A5 FR 7110229 A FR7110229 A FR 7110229A FR 7110229 A FR7110229 A FR 7110229A FR 2087823 A5 FR2087823 A5 FR 2087823A5
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2238270A | 1970-03-24 | 1970-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2087823A5 true FR2087823A5 (OSRAM) | 1971-12-31 |
Family
ID=21809307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7110229A Expired FR2087823A5 (OSRAM) | 1970-03-24 | 1971-03-23 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3654320A (OSRAM) |
| CH (1) | CH557335A (OSRAM) |
| FR (1) | FR2087823A5 (OSRAM) |
| GB (2) | GB1291036A (OSRAM) |
| NL (1) | NL7103624A (OSRAM) |
| SE (1) | SE369302B (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7978794A (en) * | 1993-10-13 | 1995-05-04 | Neurocrine Biosciences, Inc. | 3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use |
| CA2386095A1 (en) * | 1999-09-30 | 2001-04-05 | Hollis-Eden Pharmaceuticals, Inc. | Therapeutic treatment of androgen receptor driven conditions |
-
1970
- 1970-03-24 US US22382A patent/US3654320A/en not_active Expired - Lifetime
-
1971
- 1971-03-09 CH CH344871A patent/CH557335A/xx not_active IP Right Cessation
- 1971-03-18 NL NL7103624A patent/NL7103624A/xx unknown
- 1971-03-22 SE SE03670/71A patent/SE369302B/xx unknown
- 1971-03-23 FR FR7110229A patent/FR2087823A5/fr not_active Expired
- 1971-04-19 GB GB22046/71A patent/GB1291036A/en not_active Expired
- 1971-04-19 GB GB2791/72A patent/GB1291037A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1291037A (en) | 1972-09-27 |
| US3654320A (en) | 1972-04-04 |
| GB1291036A (en) | 1972-09-27 |
| CH557335A (de) | 1974-12-31 |
| SE369302B (OSRAM) | 1974-08-19 |
| NL7103624A (OSRAM) | 1971-09-28 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |